Stay updated on Gilteritinib Combo for Newly Diagnosed AML Clinical Trial

Sign up to get notified when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A banner announces changes to NIH websites and explains that some agency content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.4%
    Check dated 2026-10-25T23:10:58.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T23:30:25.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T23:38:55.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The study record history page appears unchanged, with its version list and study update categories intact.
    Difference
    0.1%
    Check dated 2026-10-04T23:19:11.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A newer site revision (v3.7.0) was added to the history. The older revision (v3.6.6) was removed.
    Difference
    0.1%
    Check dated 2026-09-20T22:53:06.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    New version entries dated 2026-09-10 and 2026-09-11 were added to the study record history, including updates to the Study Status and Contacts/Locations sections. The entry dated 2026-03-04 was removed from the history.
    Difference
    0.3%
    Check dated 2026-09-13T20:42:25.000Z thumbnail image

Stay in the know with updates to Gilteritinib Combo for Newly Diagnosed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.